A study showed "unexpected" results related to race and MDS survival... The report showed significant demographic and geographic imbalances in pivotal clinical trials leading to drug approval. A study identified differences in molecular features that may drive clinical disparities seen in patients with myeloma. Black and Hispanic patients who underwent CAR T-cell therapy had outcomes comparable to their White and Asian counterparts. A study published in Environment International reported an elevated risk of multiple myeloma (MM) among female agricultural ... In total, 668 patients were evaluated, including 126 Black patients and 542 white patients. Racial and ethnic minorities experience well-documented disparities across the cancer trajectory. This study was published in JCO Oncology Practice. Socioeconomic status (SES) and race/ethnicity should be considered when planning multiple myeloma (MM) interventions, ... Socioeconomic factors play a big role in multiple myeloma (MM) disparities, according to a study published in ... A study published in Blood Advances found that a gene linked to multiple myeloma (MM) prognosis is expressed less frequently ... This study was published in the Journal of Medical Economics. These findings were published in Clinical Lymphoma, Myeloma, & Leukemia. Patient race and ethnicity were bound to be associated with hematopoietic stem/progenitor cells mobilization. The analysis retrospectively reviewed EHR and cancer registry data recorded in the VA’s Corporate Data Warehouse. A study aimed to evaluate the pain experiences among African American patients with multiple myeloma. A study showed evidence of racial disparities in the use of IV bisphosphonates among older patients. A study published in BMC Cancer analyzed the relationship between education level and survival in multiple myeloma. Sarah Holstein, MD, PhD, discusses the lack of Black patients with multiple myeloma enrolled in clinical trials. The addition of daratumumab to standard therapy improved responses in Black transplant-eligible patients with newly diagnosed ...